Presenilin diversifies its portfolio - PubMed (original) (raw)
Review
Presenilin diversifies its portfolio
Annette L Parks et al. Trends Genet. 2007 Mar.
Abstract
Presenilin, the catalytic member of the gamma-secretase proteolytic complex, was discovered through its roles in generating Alzheimer's-disease-associated amyloid-beta peptides from the amyloid-beta precursor protein and in releasing the transcriptionally active domain of the receptor Notch. Recent work has revealed many additional cleavage substrates and interacting proteins, suggesting a diversity of roles for presenilin during development and adult life, some of which might contribute to Alzheimer's disease progression. Although many of these functions depend on the proteolytic activity of gamma-secretase, others are independent of its role as a protease. Here, we review recent data on candidate functions for presenilin and its interactors and on their potential significance in disease.
Similar articles
- Alzheimer's disease sends the wrong signals--a perspective.
Neve RL. Neve RL. Amyloid. 2008 Mar;15(1):1-4. doi: 10.1080/13506120701814608. Amyloid. 2008. PMID: 18266116 Review. - Alzheimer's disease and Notch signaling.
Woo HN, Park JS, Gwon AR, Arumugam TV, Jo DG. Woo HN, et al. Biochem Biophys Res Commun. 2009 Dec 25;390(4):1093-7. doi: 10.1016/j.bbrc.2009.10.093. Epub 2009 Oct 22. Biochem Biophys Res Commun. 2009. PMID: 19853579 Review. - Presenilins: how much more than γ-secretase?!
Coen K, Annaert W. Coen K, et al. Biochem Soc Trans. 2010 Dec;38(6):1474-8. doi: 10.1042/BST0381474. Biochem Soc Trans. 2010. PMID: 21118110 - Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J, Ayral E, Hernandez JF, Martinez J, Checler F. Sevalle J, et al. J Neurochem. 2009 Jul;110(1):275-83. doi: 10.1111/j.1471-4159.2009.06131.x. Epub 2009 Apr 29. J Neurochem. 2009. PMID: 19457123 - γ-Secretase component presenilin is important for microglia β-amyloid clearance.
Farfara D, Trudler D, Segev-Amzaleg N, Galron R, Stein R, Frenkel D. Farfara D, et al. Ann Neurol. 2011 Jan;69(1):170-80. doi: 10.1002/ana.22191. Epub 2010 Nov 22. Ann Neurol. 2011. PMID: 21280087
Cited by
- Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease.
Weggen S, Beher D. Weggen S, et al. Alzheimers Res Ther. 2012 Mar 30;4(2):9. doi: 10.1186/alzrt107. Alzheimers Res Ther. 2012. PMID: 22494386 Free PMC article. - The Role of Presenilin-1 in the Excitotoxicity of Ethanol Withdrawal.
Jung ME, Metzger DB, Das HK. Jung ME, et al. J Pharmacol Exp Ther. 2016 Sep;358(3):516-26. doi: 10.1124/jpet.116.233361. Epub 2016 Jun 8. J Pharmacol Exp Ther. 2016. PMID: 27278235 Free PMC article. - Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations.
Maarouf CL, Daugs ID, Spina S, Vidal R, Kokjohn TA, Patton RL, Kalback WM, Luehrs DC, Walker DG, Castaño EM, Beach TG, Ghetti B, Roher AE. Maarouf CL, et al. Mol Neurodegener. 2008 Nov 20;3:20. doi: 10.1186/1750-1326-3-20. Mol Neurodegener. 2008. PMID: 19021905 Free PMC article. - Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli.
Gentle ME, Rose A, Bugeon L, Dallman MJ. Gentle ME, et al. J Immunol. 2012 Aug 1;189(3):1274-84. doi: 10.4049/jimmunol.1103102. Epub 2012 Jul 2. J Immunol. 2012. PMID: 22753939 Free PMC article. - Non-Catalytic Roles of Presenilin Throughout Evolution.
Otto GP, Sharma D, Williams RS. Otto GP, et al. J Alzheimers Dis. 2016 Apr 12;52(4):1177-87. doi: 10.3233/JAD-150940. J Alzheimers Dis. 2016. PMID: 27079701 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources